CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
Bridge Percutaneous Nerve Field Stimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06071884
NCT06071884N/ACompleted

Evaluation of Bridge Device in Pain Management for Outpatient Rotator Cuff Surgery

Steven Orebaugh·interventional·Posted Oct 10, 2023·Updated Jan 14, 2026

In Brief

A clinical study evaluating Bridge Percutaneous Nerve Field Stimulator for Pain and Rotator Cuff Injuries. Completed, enrolled 42 participants across 1 site.

Detailed Summary

The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMasimo Corporation

Timeline

N/ACompletedFinished
202420252026
First PostedOct 10, 2023
Enrollment StartJul 29, 2024
Primary CompletionSep 26, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.7 years ago

Interventions

Bridge Percutaneous Nerve Field Stimulatordevice

The Bridge device is an FDA-cleared, drug-free, non-surgical device that uses neuro-modulation to aid in the reduction of symptoms associated with opioid withdrawal through application to branches of the Cranial Nerves V, VII, IX, X, and the occipital nerves. This study is investigating its effectiveness treating post-surgical pain.